AIDX

20/20 Biolabs Inc

• Benzinga·4h ago

  20/20 BioLabs Says Its OneTest For Cancer Is Now Available Through Evexia Diagnostics Platform

• TipRanks·19h ago

  20/20 BioLabs files to sell 10.1M shares of common stock for holders

• Seeking Alpha·6d ago

  20/20 Biolabs, Inc. GAAP EPS of -$0.76, revenue of $2M

• Benzinga·6d ago

  20/20 Biolabs FY EPS $(0.76) Up From $(1.16) YoY, Sales $2.045M Up From $1.752M YoY

• Dow Jones·6d ago

  Press Release: 20/20 BioLabs Reports Full Year -2-

• Dow Jones·6d ago

  Press Release: 20/20 BioLabs Reports Full Year -3-

• Dow Jones·6d ago

  Press Release: 20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress

• TipRanks·03/27 12:57

  20/20 BioLabs announces grants for Maryland fire departments to procure OneTest

• Benzinga·03/27 12:34

  20/20 BioLabs Secures $520K MDH Grant To Deploy OneTest MCED Blood Test Across Maryland Fire Departments

• NASDAQ·03/25 12:05

  20/20 BioLabs Secure U.S. License For Advanced CKD Prediction Technology

• Benzinga·03/24 21:05

  12 Health Care Stocks Moving In Tuesday's After-Market Session

• Benzinga·03/24 15:07

  What's Going On With 20/20 Biolabs Stock?

• TipRanks·03/24 12:46

  20/20 BioLabs enters exclusive technology license, access agreement with Rokit

• Benzinga·03/24 12:35

  20/20 BioLabs Partners With ROKIT To Add AI-Driven Kidney Disease Risk And Biomarker Insights To Longevity Platform

• Reuters·03/24 12:31

  20/20 BIOLABS: UNDER AGREEMENT, ROKIT AGREED TO REIMBURSE 20/20 IN EXCHANGE FOR RUNNING ROYALTY TO ROKIT ON NET SALES OF COMBINED PRODUCT